Drug profile · INN
orforglipron calcium
FOUNDAYO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
orforglipron calcium (FOUNDAYO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN orforglipron calcium
Brand FOUNDAYO
Route ORAL
Formulation TABLET
Frequently asked questions
What is orforglipron calcium?
orforglipron calcium (FOUNDAYO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for orforglipron calcium?
FOUNDAYO is a marketed brand name for orforglipron calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of orforglipron calcium?
orforglipron calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.